Segall Bryant & Hamill LLC Trims Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Segall Bryant & Hamill LLC trimmed its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 3.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 167,790 shares of the company’s stock after selling 6,779 shares during the period. Segall Bryant & Hamill LLC’s holdings in Phibro Animal Health were worth $3,524,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Geode Capital Management LLC boosted its holdings in shares of Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after purchasing an additional 27,201 shares during the period. Barclays PLC lifted its holdings in shares of Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after buying an additional 29,271 shares during the period. Algert Global LLC grew its position in shares of Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after buying an additional 59,850 shares in the last quarter. FMR LLC increased its stake in shares of Phibro Animal Health by 22.7% during the third quarter. FMR LLC now owns 39,310 shares of the company’s stock valued at $885,000 after buying an additional 7,270 shares during the period. Finally, BNP Paribas Financial Markets raised its holdings in shares of Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after acquiring an additional 729 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Stock Up 0.2 %

NASDAQ:PAHC opened at $21.68 on Friday. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The stock has a market capitalization of $878.11 million, a P/E ratio of 45.17, a P/E/G ratio of 0.45 and a beta of 0.58. The company’s 50-day simple moving average is $22.77 and its 200-day simple moving average is $22.65. Phibro Animal Health Co. has a fifty-two week low of $12.17 and a fifty-two week high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, equities analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 100.00%.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. Morgan Stanley increased their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. StockNews.com lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, Barclays upped their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the stock. Based on data from MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $21.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.